AbbVie (ABBV) Total Non-Current Liabilities (2012 - 2026)
AbbVie (ABBV) recorded Total Non-Current Liabilities of $106.45 billion in Q2 2026, up 1.1% from $105.28 billion a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie reported Total Non-Current Liabilities of $104.66 billion, up 2.9% from FY2024.
- Annual Total Non-Current Liabilities has increased for three straight years, though with a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $101.67 billion in FY2024 (+10.5%), $91.99 billion in FY2023 (+1.2%), $90.86 billion in FY2022 (-11.3%) and $102.39 billion in FY2021 (-6.8%).
- Quarterly Total Non-Current Liabilities has ranged from $88.99 billion in Q1 2023 to $108.96 billion in Q1 2026 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has increased for five consecutive quarters, with growth averaging 3.9% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 21.4% in Q1 2024, against a decline of 11.3% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $108.96 billion (Q1 2026), $104.66 billion (Q4 2025) and $104.89 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 60.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.45 Bn |
| Mar 31, 2026 | 108.96 Bn |
| Dec 31, 2025 | 104.66 Bn |
| Sep 30, 2025 | 104.89 Bn |
| Jun 30, 2025 | 105.28 Bn |
| Mar 31, 2025 | 103.51 Bn |
| Dec 31, 2024 | 101.67 Bn |
| Sep 30, 2024 | 104.32 Bn |
| Jun 30, 2024 | 102.69 Bn |
| Mar 31, 2024 | 108.05 Bn |
| Dec 31, 2023 | 91.99 Bn |
| Sep 30, 2023 | 92.45 Bn |
| Jun 30, 2023 | 90.18 Bn |
| Mar 31, 2023 | 88.99 Bn |
| Dec 31, 2022 | 90.86 Bn |
| Sep 30, 2022 | 95.08 Bn |
| Jun 30, 2022 | 97.73 Bn |
| Mar 31, 2022 | 98.87 Bn |
| Dec 31, 2021 | 102.39 Bn |
| Sep 30, 2021 | 106.18 Bn |
API Access
AbbVie Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();